Chugai and Biofourmis Collaborating to Develop Digital Solution For Objective Assessment of Pain

By
Sam Draper
-
Chugai Biofourmis partnership
Biofourmis’ Biovitals platform collects and interprets vast amounts of population metadata and compares it to real-time patient physiological signals to provide a clearer picture of chronic patients and their disease trajectory (Image: Biofourmis)
Chugai Pharmaceutical, one of Japan’s leading research-based pharmaceutical companies and Biofourmis, a Boston-based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).

RELATED ARTICLESMORE FROM AUTHOR